| scholarly article | Q13442814 |
| P2093 | author name string | Yang Zhao | |
| Chen Zhao | |||
| Shanshan Wang | |||
| Feng Du | |||
| Ling Qi | |||
| P2860 | cites work | The emerging roles of tumor-derived exosomes in hematological malignancies | Q39188856 |
| AML suppresses hematopoiesis by releasing exosomes that contain microRNAs targeting c-MYB. | Q39415910 | ||
| Cell line OCI/AML3 bears exon-12 NPM gene mutation-A and cytoplasmic expression of nucleophosmin | Q40389129 | ||
| FLT3 mutations in acute myeloid leukemia cell lines | Q40610364 | ||
| Overexpression of a dominant negative form of STAT3 selectively impairs hematopoietic stem cell activity | Q40720215 | ||
| Hematopoietic stem cells express multiple myeloid markers: implications for the origin and targeted therapy of acute myeloid leukemia | Q41925220 | ||
| Cytosolic YB-1 and NSUN2 are the only proteins recognizing specific motifs present in mRNAs enriched in exosomes | Q46397029 | ||
| Acute myeloid leukemia transforms the bone marrow niche into a leukemia-permissive microenvironment through exosome secretion. | Q47570675 | ||
| Hematopoietic stem cell-derived exosomes promote hematopoietic differentiation of mouse embryonic stem cells in vitro via inhibiting the miR126/Notch1 pathway | Q48523521 | ||
| Downregulation of hypermethylated in cancer-1 by - promotes adriamycin resistance in breast cancer cells | Q58765211 | ||
| Novel STAT3 Inhibitor LDOC1 Targets Phospho-JAK2 for Degradation by Interacting with LNX1 and Regulates the Aggressiveness of Lung Cancer | Q61799008 | ||
| Allogeneic hematopoietic stem-cell transplantation for patients 50 years or older with myelodysplastic syndromes or secondary acute myeloid leukemia | Q82236404 | ||
| Exosomes in acute myeloid leukemia inhibit hematopoiesis | Q88915677 | ||
| Sphingolipid-mediated inflammatory signaling leading to autophagy inhibition converts erythropoiesis to myelopoiesis in human hematopoietic stem/progenitor cells | Q90463779 | ||
| MicroRNA signatures associated with cytogenetics and prognosis in acute myeloid leukemia | Q24655915 | ||
| Hematopoietic stem cell niche maintenance during homeostasis and regeneration | Q26865273 | ||
| The prognostic and functional role of microRNAs in acute myeloid leukemia | Q27693865 | ||
| Linear models and empirical bayes methods for assessing differential expression in microarray experiments | Q27860758 | ||
| 'Acute myeloid leukemia: a comprehensive review and 2016 update' | Q28072539 | ||
| affy--analysis of Affymetrix GeneChip data at the probe level | Q29547353 | ||
| Exosomes: extracellular organelles important in intercellular communication | Q29620346 | ||
| Phase I study of OPB-51602, an oral inhibitor of signal transducer and activator of transcription 3, in patients with relapsed/refractory hematological malignancies | Q33422320 | ||
| microRNA-29a induces aberrant self-renewal capacity in hematopoietic progenitors, biased myeloid development, and acute myeloid leukemia | Q33730103 | ||
| LDOC1 mRNA is differentially expressed in chronic lymphocytic leukemia and predicts overall survival in untreated patients | Q34924406 | ||
| Stat3 signaling in acute myeloid leukemia: ligand-dependent and -independent activation and induction of apoptosis by a novel small-molecule Stat3 inhibitor | Q35030931 | ||
| Malignant hematopoietic cell lines: in vitro models for the study of MLL gene alterations | Q35606336 | ||
| LDOC1 inhibits proliferation and promotes apoptosis by repressing NF-κB activation in papillary thyroid carcinoma | Q36348701 | ||
| Prediction of human microRNA targets | Q36587289 | ||
| STAT3 as a target for inducing apoptosis in solid and hematological tumors | Q37029162 | ||
| Immune modulation of T-cell and NK (natural killer) cell activities by TEXs (tumour-derived exosomes) | Q37040486 | ||
| Major deletions in the gene encoding the p53 tumor antigen cause lack of p53 expression in HL-60 cells | Q37676784 | ||
| Molecular genetics of adult acute myeloid leukemia: prognostic and therapeutic implications | Q37827283 | ||
| Exosomal RNA as biomarkers and the therapeutic potential of exosome vectors. | Q38002919 | ||
| Exosomes in tumor microenvironment influence cancer progression and metastasis | Q38091978 | ||
| The role of miR-150 in normal and malignant hematopoiesis | Q38129726 | ||
| Plasma-derived exosomes in acute myeloid leukemia for detection of minimal residual disease: are we ready? | Q38886247 | ||
| Exosomes: Therapy delivery tools and biomarkers of diseases | Q39137208 | ||
| P4510 | describes a project that uses | ImageJ | Q1659584 |
| limma | Q112236343 | ||
| affy | Q113334509 | ||
| P433 | issue | 1 | |
| P921 | main subject | acute myeloid leukemia | Q264118 |
| hemopoiesis | Q919283 | ||
| P304 | page(s) | 384 | |
| P577 | publication date | 2019-12-16 | |
| P1433 | published in | Stem Cell Research & Therapy | Q14390536 |
| P1476 | title | Acute myeloid leukemia cells secrete microRNA-4532-containing exosomes to mediate normal hematopoiesis in hematopoietic stem cells by activating the LDOC1-dependent STAT3 signaling pathway | |
| P478 | volume | 10 |
| Q112715933 | Bone Marrow Mesenchymal Stem Cells-Derived Exosomal miR-425-5p Inhibits Acute Myeloid Leukemia Cell Proliferation, Apoptosis, Invasion and Migration by Targeting WTAP |
| Q112745508 | Hyperleukocytic Acute Leukemia Circulating Exosomes Regulate HSCs and BM-MSCs |
Search more.